000 | 01832 a2200505 4500 | ||
---|---|---|---|
005 | 20250514195042.0 | ||
264 | 0 | _c20050310 | |
008 | 200503s 0 0 eng d | ||
022 | _a0903-1936 | ||
024 | 7 |
_a10.1183/09031936.04.00072703 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Donnell, D E | |
245 | 0 | 0 |
_aEffect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. _h[electronic resource] |
260 |
_bThe European respiratory journal _cJul 2004 |
||
300 |
_a86-94 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAirway Resistance _xdrug effects |
650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aExercise _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInspiratory Capacity _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aRespiratory Function Tests |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSalmeterol Xinafoate |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aVoduc, N | |
700 | 1 | _aFitzpatrick, M | |
700 | 1 | _aWebb, K A | |
773 | 0 |
_tThe European respiratory journal _gvol. 24 _gno. 1 _gp. 86-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1183/09031936.04.00072703 _zAvailable from publisher's website |
999 |
_c14994042 _d14994042 |